Global Diabetes Associated Ophthalmic Treatment Market Size & Outlook
Global diabetes associated ophthalmic treatment market, 2017-2028 (US$M)
Related Markets
Global diabetes associated ophthalmic treatment market highlights
- The global diabetes associated ophthalmic treatment market generated a revenue of USD 27,156.6 million in 2020 and is expected to reach USD 44,668.9 million by 2028.
- The market is expected to grow at a CAGR (2021 - 2028) of 6.4% by 2028.
- In terms of segment, diabetic retinopathy accounted for a revenue of USD 7,177.0 million in 2020.
- Eye Allergy & Infection is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, South Africa is expected to register the highest CAGR from 2021 to 2028.
Global data book summary
| Market revenue in 2020 | USD 27,156.6 million |
| Market revenue in 2028 | USD 44,668.9 million |
| Growth rate | 6.4% (CAGR from 2020 to 2028) |
| Largest segment | Diabetic retinopathy |
| Fastest growing segment | Eye Allergy & Infection |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic-associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema, Other Application |
Other key industry trends
- In terms of revenue, the North America accounted for 36.5% of the global diabetes associated ophthalmic treatment market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, South Africa is the fastest growing regional market and is projected to reach USD 879.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Associated Ophthalmic Treatment Market Scope
Diabetes Associated Ophthalmic Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global diabetes associated ophthalmic treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes associated ophthalmic treatment market will help companies and investors design strategic landscapes.
Diabetic retinopathy was the largest segment with a revenue share of 26.43% in 2020. Horizon Databook has segmented the Global diabetes associated ophthalmic treatment market based on dry eye syndrome, glaucoma, eye allergy & infection, diabetic retinopathy, diabetic-associated macular degeneration, uveitis, cataract, diabetic macular edema, other application covering the revenue growth of each sub-segment from 2017 to 2028.
- Global Diabetes Associated Ophthalmic Treatment Application Outlook (Revenue, USD Million, 2017-2028)
- Dry Eye Syndrome
- Glaucoma
- Eye Allergy & Infection
- Diabetic Retinopathy
- Diabetic-associated Macular Degeneration
- Uveitis
- Cataract
- Diabetic Macular Edema
- Other Application
- Global Diabetes Associated Ophthalmic Treatment Type Outlook (Revenue, USD Million, 2017-2028)
- Drugs
- Devices
- Global Diabetes Associated Ophthalmic Treatment End Use Outlook (Revenue, USD Million, 2017-2028)
- Hospitals
- Ophthalmic Centers
- Ambulatory Centers
- Others End Use
Reasons to subscribe to Global diabetes associated ophthalmic treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global diabetes associated ophthalmic treatment market databook
-
Our clientele includes a mix of diabetes associated ophthalmic treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global diabetes associated ophthalmic treatment market, including forecasts for subscribers. This global databook contains high-level insights into Global diabetes associated ophthalmic treatment market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global diabetes associated ophthalmic treatment market size, by regions, 2017-2028 (US$M)
Top 10 countries: Diabetes associated ophthalmic treatment market size, 2020 (US$M)
Global diabetes associated ophthalmic treatment market share, by application, 2020 & 2028 (%, US$M)
Diabetes associated ophthalmic treatment market: Opportunity assessment by country
Global diabetes associated ophthalmic treatment market, by region, 2020 (US$M)
| Application | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 8,894.1 | 9,405.8 | 9,971.4 | 9,906.7 | 10,512.9 | 11,170.6 | 11,884.9 | 12,661.1 | 13,505.5 | 14,424.7 | 15,426.2 | 16,518.6 | 6.6% |
| Europe | 6,683.5 | 7,051.3 | 7,457.7 | 7,392.0 | 7,855.4 | 8,358.5 | 8,905.4 | 9,500.1 | 10,147.7 | 10,853.2 | 11,622.7 | 12,462.6 | 6.8% |
| Asia Pacific | 5,170.4 | 5,379.8 | 5,610.7 | 5,482.9 | 5,833.6 | 6,214.7 | 6,629.2 | 7,080.3 | 7,571.7 | 8,107.6 | 8,692.5 | 9,331.3 | 6.9% |
| Latin America | 2,259.9 | 2,424.6 | 2,606.9 | 2,626.1 | 2,750.0 | 2,883.1 | 3,026.1 | 3,179.9 | 3,345.4 | 3,523.5 | 3,715.3 | 3,921.9 | 5.1% |
| MEA | 1,636.4 | 1,707.0 | 1,784.9 | 1,748.9 | 1,817.1 | 1,889.8 | 1,967.1 | 2,049.3 | 2,136.8 | 2,230.0 | 2,329.0 | 2,434.5 | 4.2% |
| Overall | 24,644.2 | 25,968.5 | 27,431.5 | 27,156.6 | 28,769.0 | 30,516.7 | 32,412.6 | 34,470.8 | 36,707.1 | 39,138.9 | 41,785.7 | 44,668.9 | 6.4% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
